These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

654 related articles for article (PubMed ID: 14501840)

  • 21. Treatment of inflammatory myopathies.
    Mastaglia FL; Laing BA; Zilko P
    Baillieres Clin Neurol; 1993 Nov; 2(3):717-40. PubMed ID: 8156149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The practice guideline 'Dermatomyositis, polymyositis and sporadic inclusion body myositis'].
    Hoogendijk JE; Bijlsma JW; van Engelen BG; Lindeman E; van Royen-Kerkhof A; de Rie MA; de Visser M; Jennekens FG;
    Ned Tijdschr Geneeskd; 2005 Sep; 149(38):2104-11. PubMed ID: 16201600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
    Adams EM; Pucino F; Yarboro C; Hicks JE; Thornton B; McGarvey C; Sonies BC; Bartlett ML; Villalba ML; Fleisher T; Plotz PH
    J Rheumatol; 1999 Feb; 26(2):352-60. PubMed ID: 9972969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current treatment of the inflammatory myopathies.
    Dalakas MC
    Curr Opin Rheumatol; 1994 Nov; 6(6):595-601. PubMed ID: 7865379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polymyositis and dermatomyositis.
    Dalakas MC; Hohlfeld R
    Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exercise effects in patients with adult idiopathic inflammatory myopathies.
    Alexanderson H
    Curr Opin Rheumatol; 2009 Mar; 21(2):158-63. PubMed ID: 19339927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory Myopathies with Cutaneous Involvement: from Diagnosis to Therapy.
    Dourmishev LA
    Folia Med (Plovdiv); 2017 Mar; 59(1):7-13. PubMed ID: 28384112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation and treatment of inflammatory myopathies.
    Amato AA; Barohn RJ
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1060-8. PubMed ID: 19762898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
    Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
    Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory myopathies [polymyositis, dermatomyositis, inclusion body myositis].
    Bertorini TE
    Compr Ther; 1998 Oct; 24(10):494-502. PubMed ID: 9801848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An overview of polymyositis and dermatomyositis.
    Findlay AR; Goyal NA; Mozaffar T
    Muscle Nerve; 2015 May; 51(5):638-56. PubMed ID: 25641317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus.
    Limaye VS; Lester S; Blumbergs P; Roberts-Thomson PJ
    Int J Rheum Dis; 2010 May; 13(2):132-7. PubMed ID: 20536597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
    Mastaglia FL; Garlepp MJ; Phillips BA; Zilko PJ
    Muscle Nerve; 2003 Apr; 27(4):407-25. PubMed ID: 12661042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intravenous immunoglobulins in chronic idiopathic myositis].
    Michels H; Burmester GR; Buttgereit F
    Z Rheumatol; 2005 Mar; 64(2):102-10. PubMed ID: 15793676
    [No Abstract]   [Full Text] [Related]  

  • 35. Inflammatory myopathies: how to treat the difficult cases.
    Mastaglia FL; Zilko PJ
    J Clin Neurosci; 2003 Jan; 10(1):99-101. PubMed ID: 12464534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
    Askanas V; Engel WK; Mirabella M
    Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Dysimmune and inflammatory myopathies].
    Authier FJ
    Rev Prat; 2008 Dec; 58(20):2253-60. PubMed ID: 19209656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of intravenous immunoglobulin therapy for myositis: an audit in South Australian patients.
    Foreman C; Russo P; Davies N; Hissaria P; Proudman S; Hughes T; Limaye V
    Intern Med J; 2017 Jan; 47(1):112-115. PubMed ID: 28076913
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiopathic inflammatory myopathies: current and future therapeutic options.
    Wiendl H
    Neurotherapeutics; 2008 Oct; 5(4):548-57. PubMed ID: 19019306
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Exercise is beneficial for patients with myositis. Both pharmaceuticals and physical activity should be included in the therapy of chronic rheumatic muscle inflammation].
    Lundberg IE; Alexanderson H; Arnardottir S; Borg K
    Lakartidningen; 2003 Sep; 100(36):2754-9. PubMed ID: 14558188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.